Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02738684
What this trial is testing

Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test

Who this might be right for
Lung Adenocarcinoma
Southwest Hospital, China 100
Large-scale testing (Phase 3)Study completedNCT00322452
What this trial is testing

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 1,329
Testing effectiveness (Phase 2)UnknownNCT00282100
What this trial is testing

Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Tan Tock Seng Hospital 40
Early research (Phase 1)Study completedNCT00252798
What this trial is testing

ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Carcinoma
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT00075439
What this trial is testing

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT00041106
What this trial is testing

Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00242749
What this trial is testing

IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma

Who this might be right for
Cancer of Head and Neck
AstraZeneca 47
Testing effectiveness (Phase 2)Study completedNCT00113529
What this trial is testing

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer 42
Testing effectiveness (Phase 2)Study completedNCT00234403
What this trial is testing

A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT00635856
What this trial is testing

Open Label Trial to Assess Iressa in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT00024154
What this trial is testing

Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 132
Not applicableStudy completedNCT02148380
What this trial is testing

Combination of Chemotherapy and Gefitinib as First-line Treatment

Who this might be right for
Non-Small-Cell Lung Cancer
Baohui Han 121
Large-scale testing (Phase 3)Study completedNCT00193596
What this trial is testing

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

Who this might be right for
Neoplasms, Unknown Primary
SCRI Development Innovations, LLC 198
Testing effectiveness (Phase 2)Study completedNCT00344773
What this trial is testing

First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation

Who this might be right for
Pulmonary Cancer
AstraZeneca 46
Testing effectiveness (Phase 2)UnknownNCT01955421
What this trial is testing

Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc

Who this might be right for
Advanced Stage Non Small Cell Lung Cancer
Sun Yat-sen University 224
Testing effectiveness (Phase 2)Study completedNCT00239304
What this trial is testing

Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer

Who this might be right for
Head and Neck Neoplasms
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT02976116
What this trial is testing

A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Hutchison Medipharma Limited 50
Early research (Phase 1)Study completedNCT00255489
What this trial is testing

A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
AstraZeneca 36
Large-scale testing (Phase 3)UnknownNCT04028778
What this trial is testing

Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Sun Yat-sen University 310
Testing effectiveness (Phase 2)Study completedNCT00025116
What this trial is testing

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 40
Next Page